Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation

Transplantation

Volumn 87, Issue 3, 2009, Pages 393-396

  Haimila, Katri ^a   Turpeinen, Hannu ^a   Alakulppi, Noora S ^a   Kyllönen, Lauri E ^b   Salmela, Kaija T ^b   Partanen, Jukka ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Association; DGF; ICOS; Organ transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CD28 ANTIGEN; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; ICOSLG PROTEIN, HUMAN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; LEUKOCYTE ANTIGEN; PDCD1LG2 PROTEIN, HUMAN; SIGNAL PEPTIDE; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; ICOS GENE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PPCD1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; CHROMOSOME 2; GENETIC MARKER; GENETICS; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENETIC MARKERS; GENETIC VARIATION; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61849160430     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318192897a     Document Type: Article

References (17)

1. Takemoto S, Port FK, Claas FH, et al. HLA matching for kidney transplantation. Hum Immunol 2004; 65: 1489.
2. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - A general susceptibility gene to autoimmunity? Genes Immun 2000; 1: 170.
3. Haimila K, Smedberg T, Mustalahti K, et al. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun 2004; 5: 85.
4. Castelli L, Comi C, Chiocchetti A, et al. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J Neuroimmunol 2007; 186: 193.
5. Slavcheva E, Albanis E, Jiao Q, et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 2001; 72: 935.
6. Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 49 and TNF-alpha -308 single nucleotide polymorphisms: A preliminary study. Transpl Immunol 2006; 16: 194.
7. Wisniewski A, Kusztal M, Magott-Procelewska M, et al. Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant Proc 2006; 38: 56.
8. Dmitrienko S, Hoar DI, Balshaw R, et al. Immune response gene polymorphisms in renal transplant recipients. Transplantation 2005; 80: 1773.
9. Snanoudj R, de Preneuf H, Creput C, et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006; 19: 693.
10. Ozkaynak E, Gao W, Shemmeri N, et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591.
11. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813.
12. Alakulppi NS, Kyllonen LE, Partanen J, et al. Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation. Nephrol Dial Transplant 2008; 23: 364.
13. Haimila KE, Partanen JA, Holopainen PM. Genetic polymorphism of the human ICOS gene. Immunogenetics 2002; 53: 1028.
14. Tantravahi J, Womer KL, Kaplan B. Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med 2007; 58: 369.
15. Kaartinen T, Lappalainen J, Haimila K, et al. Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4. Mol Immunol 2007; 44: 1644.
16. Harada H, Salama AD, Sho M, et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003; 112: 234.
17. Brophy K, Ryan AW, Thornton JM, et al. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun 2006; 7: 19.